The store will not work correctly when cookies are disabled.
6-Methyl-N'-(3,4,5-trimethoxybenzylidene)imidazo[2,1-b]thiazole-5-carbohydrazide
ID: ALA3763789
PubChem CID: 45918831
Max Phase: Preclinical
Molecular Formula: C17H18N4O4S
Molecular Weight: 374.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(/C=N/NC(=O)c2c(C)nc3sccn23)cc(OC)c1OC
Standard InChI: InChI=1S/C17H18N4O4S/c1-10-14(21-5-6-26-17(21)19-10)16(22)20-18-9-11-7-12(23-2)15(25-4)13(8-11)24-3/h5-9H,1-4H3,(H,20,22)/b18-9+
Standard InChI Key: UZVRCSHDYZILHY-GIJQJNRQSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
1.7333 -0.7256 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2217 -0.7054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2419 0.7054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9876 1.5922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1968 0.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9876 -1.5720 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1968 -0.7054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7333 0.7457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5978 1.9688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0950 3.0584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0924 1.8325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9585 3.0582 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4531 2.9219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.3193 4.1476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8133 4.0136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.6764 5.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0456 6.6013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5516 6.7354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.6884 5.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.9176 8.0958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.7222 8.2013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.9067 7.8305 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-9.4004 8.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.1710 5.1031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-11.6741 4.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3360 -1.0828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
1 5 1 0
6 7 1 0
7 8 2 0
2 6 2 0
3 8 1 0
11 12 1 0
9 10 2 0
9 11 1 0
8 9 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 2 0
20 21 1 0
18 20 1 0
22 23 1 0
17 22 1 0
24 25 1 0
16 24 1 0
12 13 2 0
7 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 374.42 | Molecular Weight (Monoisotopic): 374.1049 | AlogP: 2.49 | #Rotatable Bonds: 6 |
Polar Surface Area: 86.45 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.51 | CX Basic pKa: 2.65 | CX LogP: 1.36 | CX LogD: 1.36 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.53 | Np Likeness Score: -1.82 |
References
1. Samala G, Devi PB, Saxena S, Meda N, Yogeeswari P, Sriram D.. (2016) Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 24 (6): [PMID:26867485] [10.1016/j.bmc.2016.01.059] |